Tucuvi, established in 2019, is a pioneering entity headquartered in the United States that has positioned itself as a leader in the intersection of AI, Healthcare, and Medical Devices. Their offering, branded as Clinical Voice AI, revolutionizes care management for healthcare systems on a global scale.
The platform orchestrates end-to-end automation and coordination of clinical workflows, transitioning healthcare systems from siloed automation to a proactive care model. A standout feature is LOLA, an AI agent that seamlessly integrates with existing infrastructure, facilitating patient phone interactions and automating up to 80% of nursing workflows, ensuring over 90% patient engagement.
In Europe, Tucuvi garnered a noteworthy milestone as the first Class IIb SaMD certified AI platform for its voice AI and patient management capabilities. Their platform is currently operational across 60+ healthcare organizations, launching 50+ care workflows with significant improvements in chronic care management.
Boasting a recent €17.14M Series A investment from investors such as Cathay Innovation, Frontline Ventures, and K Fund, Tucuvi is well-poised for continued growth and innovation in the healthcare AI sector.